Cardiovascular regression in HARBOR study: Video with John Kitchens, MD

John Kitchens, MD, gives perspective on cardiovascular regression with both high- and low-dose Lucentis (ranibizumab injection; Genentech) in the HARBOR study. Click the video below to watch.

Full Story →